Takahira Kuno, Kenji Tamura, Nobutaka Shimizu, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Hirofumi Satake, Kohji Sawada, Ichiro Yamasaki, et al. Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume. Research and Reports in Urology. 2023. Volume 15. 157-164
Satoshi Fukata, Keisuke Mizutani, Shinkuro Yamamoto, Takahira Kuno, Hideo Fukuhara, Shingo Ashida, Takashi Karashima, Keiji Inoue. Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma. Anti-cancer drugs. 2022. 33. 5. 459-466
Takahira Kuno, Kenji Tamura, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Kohji Sawada, Masaharu Yasuda, Hironobu Watanabe, Fumito Komatsu, et al. Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting. Urologia Internationalis. 2021. 106. 10. 1005-1011